ANGIODYNAMICS INC Annual Deferred Federal Income Tax Expense (Benefit) in USD from 2018 to 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Angiodynamics Inc annual Deferred Federal Income Tax Expense (Benefit) history and growth rate from 2018 to 2023.
- Angiodynamics Inc annual Deferred Federal Income Tax Expense (Benefit) for 2023 was -$7.04M, a 3300% decline from 2022.
- Angiodynamics Inc annual Deferred Federal Income Tax Expense (Benefit) for 2022 was -$207K, a 93.9% increase from 2021.
- Angiodynamics Inc annual Deferred Federal Income Tax Expense (Benefit) for 2021 was -$3.42M, a 1.19% decline from 2020.
Deferred Federal Income Tax Expense (Benefit), Annual (USD)
Deferred Federal Income Tax Expense (Benefit), YoY Annual Growth (%)